Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation

Raul E. Piña-Aguilar, Gerardo R. Zaragoza-Arévalo, Isabella Rau, Andreas Gal, Miguel A. Alcántara-Ortigoza, Mónica S. López-Martínez, Yuritzi Santillán-Hernández*

*Corresponding author for this work

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We report a Mexican girl showing the full blown clinical picture of mucopolysaccharidosis type II (MPSII). Iduronate-2-sulfatase (IDS) activity was low and she carried a heterozygous de novo c.1327C>T transition in exon 9, that changes codon 443 for a premature stop (TGA; p.Arg443*). Analysis of X-chromosome inactivation in androgen receptor (AR) locus showed a highly skewed ratio of 92:8 suggesting a functional hemizygosity with dominant expression of the mutant IDS and explaining the disease manifestation. This is one of the rare cases of females affected by MPSII due to the combined effect of a skewed X-chromosome inactivation and a de novo IDS mutation. We recommend that clinicians should consider the diagnosis of MPSII even in a girl without positive family history for this condition.

Original languageEnglish
Pages (from-to)159-162
Number of pages4
JournalEuropean Journal of Medical Genetics
Volume56
Issue number3
Early online date8 Dec 2012
DOIs
Publication statusPublished - Mar 2013
Event12th International Symposium on MPS and Related Diseases - Noordwijkerhout, Netherlands
Duration: 28 Jun 20121 Jul 2012

Fingerprint

Iduronate Sulfatase
Mucopolysaccharidosis II
X Chromosome Inactivation
Mutation
Genes
Androgen Receptors
Codon
Exons

Keywords

  • Elaprase®
  • Hunter syndrome
  • Iduronate-2-sulfatase
  • Mexico
  • MPSII
  • X-linked disease

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation. / Piña-Aguilar, Raul E.; Zaragoza-Arévalo, Gerardo R.; Rau, Isabella; Gal, Andreas; Alcántara-Ortigoza, Miguel A.; López-Martínez, Mónica S.; Santillán-Hernández, Yuritzi.

In: European Journal of Medical Genetics, Vol. 56, No. 3, 03.2013, p. 159-162.

Research output: Contribution to journalArticle

Piña-Aguilar, Raul E. ; Zaragoza-Arévalo, Gerardo R. ; Rau, Isabella ; Gal, Andreas ; Alcántara-Ortigoza, Miguel A. ; López-Martínez, Mónica S. ; Santillán-Hernández, Yuritzi. / Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation. In: European Journal of Medical Genetics. 2013 ; Vol. 56, No. 3. pp. 159-162.
@article{6a66bb66b2334f7ea5a3cf344852dc98,
title = "Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation",
abstract = "We report a Mexican girl showing the full blown clinical picture of mucopolysaccharidosis type II (MPSII). Iduronate-2-sulfatase (IDS) activity was low and she carried a heterozygous de novo c.1327C>T transition in exon 9, that changes codon 443 for a premature stop (TGA; p.Arg443*). Analysis of X-chromosome inactivation in androgen receptor (AR) locus showed a highly skewed ratio of 92:8 suggesting a functional hemizygosity with dominant expression of the mutant IDS and explaining the disease manifestation. This is one of the rare cases of females affected by MPSII due to the combined effect of a skewed X-chromosome inactivation and a de novo IDS mutation. We recommend that clinicians should consider the diagnosis of MPSII even in a girl without positive family history for this condition.",
keywords = "Elaprase{\circledR}, Hunter syndrome, Iduronate-2-sulfatase, Mexico, MPSII, X-linked disease",
author = "Pi{\~n}a-Aguilar, {Raul E.} and Zaragoza-Ar{\'e}valo, {Gerardo R.} and Isabella Rau and Andreas Gal and Alc{\'a}ntara-Ortigoza, {Miguel A.} and L{\'o}pez-Mart{\'i}nez, {M{\'o}nica S.} and Yuritzi Santill{\'a}n-Hern{\'a}ndez",
note = "We are very grateful to the family of the patient that, in spite of the pain of having their daughter suffering of MPS and later the pain of losing her, cooperated with us and agreed to the publication of this case. We thank the Laboratory of Genetics from CMN “20 de Noviembre” ISSSTE, especially to M. Concepcion Yerena de Vega, for cytogenetic analysis of the case. We are also grateful to Dr. Joaqu{\'i}n Carrillo-Farga from Instituto de Hematopatologia, Mexico for his expertise in blood smear analysis and to Dr. Paula A. Rozenfeld from LISIN, Argentina for enzymatic analysis.",
year = "2013",
month = "3",
doi = "10.1016/j.ejmg.2012.11.006",
language = "English",
volume = "56",
pages = "159--162",
journal = "European Journal of Medical Genetics",
issn = "1769-7212",
publisher = "Elsevier Masson SAS",
number = "3",

}

TY - JOUR

T1 - Mucopolysaccharidosis type II in a female carrying a heterozygous stop mutation of the iduronate-2-sulfatase gene and showing a skewed X chromosome inactivation

AU - Piña-Aguilar, Raul E.

AU - Zaragoza-Arévalo, Gerardo R.

AU - Rau, Isabella

AU - Gal, Andreas

AU - Alcántara-Ortigoza, Miguel A.

AU - López-Martínez, Mónica S.

AU - Santillán-Hernández, Yuritzi

N1 - We are very grateful to the family of the patient that, in spite of the pain of having their daughter suffering of MPS and later the pain of losing her, cooperated with us and agreed to the publication of this case. We thank the Laboratory of Genetics from CMN “20 de Noviembre” ISSSTE, especially to M. Concepcion Yerena de Vega, for cytogenetic analysis of the case. We are also grateful to Dr. Joaquín Carrillo-Farga from Instituto de Hematopatologia, Mexico for his expertise in blood smear analysis and to Dr. Paula A. Rozenfeld from LISIN, Argentina for enzymatic analysis.

PY - 2013/3

Y1 - 2013/3

N2 - We report a Mexican girl showing the full blown clinical picture of mucopolysaccharidosis type II (MPSII). Iduronate-2-sulfatase (IDS) activity was low and she carried a heterozygous de novo c.1327C>T transition in exon 9, that changes codon 443 for a premature stop (TGA; p.Arg443*). Analysis of X-chromosome inactivation in androgen receptor (AR) locus showed a highly skewed ratio of 92:8 suggesting a functional hemizygosity with dominant expression of the mutant IDS and explaining the disease manifestation. This is one of the rare cases of females affected by MPSII due to the combined effect of a skewed X-chromosome inactivation and a de novo IDS mutation. We recommend that clinicians should consider the diagnosis of MPSII even in a girl without positive family history for this condition.

AB - We report a Mexican girl showing the full blown clinical picture of mucopolysaccharidosis type II (MPSII). Iduronate-2-sulfatase (IDS) activity was low and she carried a heterozygous de novo c.1327C>T transition in exon 9, that changes codon 443 for a premature stop (TGA; p.Arg443*). Analysis of X-chromosome inactivation in androgen receptor (AR) locus showed a highly skewed ratio of 92:8 suggesting a functional hemizygosity with dominant expression of the mutant IDS and explaining the disease manifestation. This is one of the rare cases of females affected by MPSII due to the combined effect of a skewed X-chromosome inactivation and a de novo IDS mutation. We recommend that clinicians should consider the diagnosis of MPSII even in a girl without positive family history for this condition.

KW - Elaprase®

KW - Hunter syndrome

KW - Iduronate-2-sulfatase

KW - Mexico

KW - MPSII

KW - X-linked disease

UR - http://www.scopus.com/inward/record.url?scp=84874314465&partnerID=8YFLogxK

U2 - 10.1016/j.ejmg.2012.11.006

DO - 10.1016/j.ejmg.2012.11.006

M3 - Article

VL - 56

SP - 159

EP - 162

JO - European Journal of Medical Genetics

JF - European Journal of Medical Genetics

SN - 1769-7212

IS - 3

ER -